Gene therapy holds immense promise for managing or even curing diseases once considered untreatable. Conditions like certain cancers, β-thalassemia, and retinal dystrophy benefit from this
So, what exactly are AAVs? Adeno-associated viruses (AAVs) were first identified in 1965 by Bob Atchison and Wallace Rowe, who observed them as replication-defective particles
Adeno-associated viruses (AAVs) have emerged as a powerful tool for gene therapy due to their unique properties: Non-pathogenic AAVs are non-pathogenic, making them safe for
Contact our Customer Care, Sales & Scientific Assistance
Consult and asked questions about our products & services
Documentation of Technical & Safety Data Sheet, Guides and more...